Marleen M.R. Petit

1.2k total citations
17 papers, 878 citations indexed

About

Marleen M.R. Petit is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cell Biology. According to data from OpenAlex, Marleen M.R. Petit has authored 17 papers receiving a total of 878 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Cell Biology. Recurrent topics in Marleen M.R. Petit's work include Sarcoma Diagnosis and Treatment (7 papers), RNA Research and Splicing (6 papers) and Hippo pathway signaling and YAP/TAZ (4 papers). Marleen M.R. Petit is often cited by papers focused on Sarcoma Diagnosis and Treatment (7 papers), RNA Research and Splicing (6 papers) and Hippo pathway signaling and YAP/TAZ (4 papers). Marleen M.R. Petit collaborates with scholars based in Belgium, Sweden and United States. Marleen M.R. Petit's co-authors include Wim J.M. Van de Ven, Nils Mandahl, Torik Ayoubi, Sandra Meulemans, Raf Mols, Erik Jansen, Roy M. Golsteyn, Daniel Louvard, Evelyne Friederich and Bernadette Menichi and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Circulation Research.

In The Last Decade

Marleen M.R. Petit

17 papers receiving 866 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marleen M.R. Petit Belgium 15 513 229 193 164 162 17 878
François Blanchette Canada 10 521 1.0× 112 0.5× 63 0.3× 174 1.1× 88 0.5× 17 943
Mingzhe Zheng China 19 497 1.0× 147 0.6× 75 0.4× 155 0.9× 203 1.3× 43 1.1k
Zhizhan Gu United States 13 443 0.9× 327 1.4× 138 0.7× 75 0.5× 129 0.8× 16 905
Benoît Langlois France 15 358 0.7× 226 1.0× 75 0.4× 247 1.5× 250 1.5× 19 857
Tanya A. Rege United States 8 339 0.7× 73 0.3× 148 0.8× 108 0.7× 90 0.6× 13 735
Marie‐Hélène Laprise Canada 7 486 0.9× 135 0.6× 52 0.3× 174 1.1× 83 0.5× 7 783
Keiko Mayne Australia 12 590 1.2× 397 1.7× 79 0.4× 118 0.7× 87 0.5× 17 849
John L. Blount United States 10 249 0.5× 46 0.2× 136 0.7× 121 0.7× 193 1.2× 10 814
Shinji Mii Japan 23 721 1.4× 158 0.7× 108 0.6× 227 1.4× 105 0.6× 63 1.3k
S Godyna United States 9 389 0.8× 161 0.7× 91 0.5× 214 1.3× 191 1.2× 12 783

Countries citing papers authored by Marleen M.R. Petit

Since Specialization
Citations

This map shows the geographic impact of Marleen M.R. Petit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marleen M.R. Petit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marleen M.R. Petit more than expected).

Fields of papers citing papers by Marleen M.R. Petit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marleen M.R. Petit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marleen M.R. Petit. The network helps show where Marleen M.R. Petit may publish in the future.

Co-authorship network of co-authors of Marleen M.R. Petit

This figure shows the co-authorship network connecting the top 25 collaborators of Marleen M.R. Petit. A scholar is included among the top collaborators of Marleen M.R. Petit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marleen M.R. Petit. Marleen M.R. Petit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Janssens, Veerle, Karen Zwaenepoel, Carine Rossé, et al.. (2016). PP2A binds to the LIM domains of lipoma-preferred partner through its PR130/B″ subunit to regulate cell adhesion and migration. Journal of Cell Science. 129(8). 1605–1618. 19 indexed citations
2.
Sayin, Volkan I., Anna Staffas, Erik Larsson, et al.. (2013). Zinc Finger Protein 148 Is Dispensable for Primitive and Definitive Hematopoiesis in Mice. PLoS ONE. 8(7). e70022–e70022. 5 indexed citations
3.
Sayin, Volkan I., Mohamed X. Ibrahim, Erik Larsson, et al.. (2013). Zfp148 Deficiency Causes Lung Maturation Defects and Lethality in Newborn Mice That Are Rescued by Deletion of p53 or Antioxidant Treatment. PLoS ONE. 8(2). e55720–e55720. 14 indexed citations
4.
Vervenne, Hilke, Lara Carvalho, Mathias Köppen, et al.. (2008). Lpp is involved in Wnt/PCP signaling and acts together with Scrib to mediate convergence and extension movements during zebrafish gastrulation. Developmental Biology. 320(1). 267–277. 23 indexed citations
5.
Vervenne, Hilke, et al.. (2008). Targeted disruption of the mouse Lipoma Preferred Partner gene. Biochemical and Biophysical Research Communications. 379(2). 368–373. 26 indexed citations
6.
Petit, Marleen M.R., Erik Larsson, Erney Mattsson, et al.. (2008). Smooth Muscle Expression of Lipoma Preferred Partner Is Mediated by an Alternative Intronic Promoter That Is Regulated by Serum Response Factor/Myocardin. Circulation Research. 103(1). 61–69. 15 indexed citations
7.
Cleynen, Isabelle, Kristel Peeters, Maria Dêbiec‐Rychter, et al.. (2007). HMGA2 Regulates Transcription of the Imp2 Gene via an Intronic Regulatory Element in Cooperation with Nuclear Factor-κB. Molecular Cancer Research. 5(4). 363–372. 81 indexed citations
8.
Guo, Baoqiang, Amanda Greenall, Marleen M.R. Petit, et al.. (2006). The LIM Domain Protein LPP Is a Coactivator for the ETS Domain Transcription Factor PEA3. Molecular and Cellular Biology. 26(12). 4529–4538. 50 indexed citations
9.
Petit, Marleen M.R., et al.. (2005). The tumor suppressor Scrib interacts with the zyxin-related protein LPP, which shuttles between cell adhesion sites and the nucleus. BMC Cell Biology. 6(1). 1–1. 80 indexed citations
10.
Petit, Marleen M.R., et al.. (2005). The tumor suppressor Scrib selectively interacts with specific members of the zyxin family of proteins. FEBS Letters. 579(22). 5061–5068. 33 indexed citations
11.
Ven, Wim J.M. Van de, et al.. (2005). Transactivation Functions of the Tumor-Specific HMGA2/LPP Fusion Protein Are Augmented by Wild-Type HMGA2. Molecular Cancer Research. 3(2). 63–70. 18 indexed citations
12.
13.
Petit, Marleen M.R., Sandra Meulemans, & Wim J.M. Van de Ven. (2003). The Focal Adhesion and Nuclear Targeting Capacity of the LIM-containing Lipoma-preferred Partner (LPP) Protein. Journal of Biological Chemistry. 278(4). 2157–2168. 64 indexed citations
14.
Petit, Marleen M.R., Roy M. Golsteyn, Torik Ayoubi, et al.. (2000). LPP, an Actin Cytoskeleton Protein Related to Zyxin, Harbors a Nuclear Export Signal and Transcriptional Activation Capacity. Molecular Biology of the Cell. 11(1). 117–129. 122 indexed citations
15.
Petit, Marleen M.R., et al.. (1999). LHFP,a Novel Translocation Partner Gene ofHMGICin a Lipoma, Is a Member of a New Family ofLHFP-like Genes. Genomics. 57(3). 438–441. 69 indexed citations
16.
Petit, Marleen M.R., et al.. (1998). Expression of Reciprocal Fusion Transcripts of the HMGIC and LPP Genes in Parosteal Lipoma. Cancer Genetics and Cytogenetics. 106(1). 18–23. 44 indexed citations
17.
Petit, Marleen M.R., et al.. (1996). LPP,the Preferred Fusion Partner Gene ofHMGICin Lipomas, Is a Novel Member of the LIM Protein Gene Family. Genomics. 36(1). 118–129. 158 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026